https://www.send2press.com/wire/asco-2008-tumor-targeted-rexin-g-demonstrates-dose-dependent-anti-tumor-activity-without-toxicity-in-metastatic-pancreatic-cancer/
ASCO 2008: Tumor-Targeted Rexin-G Demonstrates Dose-Dependent Anti-Tumor Activity without Toxicity...
May 19, 2008 - SAN MARINO, Calif., May 19 (SEND2PRESS NEWSWIRE) -- Epeius Biotechnologies announced today the results of an on-going Phase I/II study of Rexin-G for...
rexin gdose dependentascotumortargeted